Background Current understanding of severe respiratory syncytial virus (RSV) infections in
adults is limited by clinical underrecognition. We compared the prevalence, clinical …

Early influenza activity during the 2012–13 season (1) enabled estimation of the unadjusted
effectiveness of the seasonal influenza vaccine (2). This report presents updated adjusted …

Background Influenza causes significant morbidity and mortality and stresses hospital
resources during periods of increased circulation. We evaluated the effectiveness of the 2019–…

Background Acute respiratory infections (ARIs) result in millions of illnesses and hundreds
of thousands of hospitalizations annually in the United States. The responsible viruses …

Background Seasonal influenza causes substantial morbidity and mortality in older adults.
High-dose inactivated influenza vaccine (HD-IIV), with increased antigen content compared to …

Background Yearly influenza immunization is recommended for immunocompromised (IC)
individuals, although immune responses are lower than that for the nonimmunocompromised …

Background Novel coronavirus disease 2019 (COVID-19) is frequently compared with
influenza. The Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) conducts …

A multicenter, double-blind, randomized, placebo-controlled trial was conducted to
determine whether the addition of penicillin was superior to patient education and anti-inflammatory …

Background An evidence-based, step-by-step guide, the 4 Pillars™ Practice Transformation
Program, was the foundation of an intervention to increase adult immunizations in primary …

Background The 2016–2017 and 2017–2018 influenza seasons were notable for the high
number of hospitalizations for influenza A(H3N2) despite vaccine and circulating strain match. …